Sep 2025· Journal of Chemical Information and Modeling· Vol 66, pp. 8579 - 8593· 1 citation· 37 references
Computer ScienceMedicineBiology
TL;DR
LINKER is the first sequence-based model to predict residue-functional group interactions according to biologically defined interaction types, using only a protein sequence and the SMILES representation of the ligand, and requires only sequence-level input at inference.
Abstract
Accurate identification of interactions between protein residues and ligand functional groups is critical for understanding molecular recognition and guiding rational drug design. Existing deep learning approaches for protein–ligand interpretability typically rely on three-dimensional structural input or distance-based contact labels, which limit both their applicability and biological relevance. Here, we present LINKER, the first sequence-based model to predict residue-functional group interactions according to biologically defined interaction types, using only a protein sequence and the SMILES representation of the ligand. LINKER is trained via structure-supervised interaction learning, in which interaction labels are derived from three-dimensional protein–ligand complexes through functional group-based motif extraction. By representing ligands as ensembles of functional groups, the model emphasizes chemically meaningful substructures rather than mere spatial proximity. Importantly, LINKER requires only sequence-level input at inference, enabling large-scale applications in contexts where structural data are unavailable. Extensive experiments demonstrate that LINKER consistently outperforms established baselines, highlighting the utility of functional group abstractions and structure-based supervision for interpretable protein–ligand interaction prediction. Our source code is publicly available at: https://github.com/HySonLab/LINKER/.
MIRAGE provides an interpretable and robust framework for structure-aware prediction, with potential applications in protein engineering and drug design, and explicitly modeling multi-level interactions is important for accurately capturing the determinants of binding affinity.
Accurate identification of near-native ligand binding poses is a central challenge in structure-based drug design. From a physical point of view, the successful construction of a protein-ligand complex structure is dependent on whether protein and ligand can form enough atomically pairwise interactions that result in a...
Zhen-Qiang Zhang, Zhihao Wang, Yang Liu et al.· Journal of Chemical Informat...· 0 citations
A structure-based method using SE(3)-transformers to learn residue compatibility with the local structural environment from experimentally resolved kinase 3D structures that captures biologically meaningful relationships between residue identity and 3D structural context is presented.
Shakiba Fadaei, F. Krebs, V. Zoete· Bioinformatics· 0 citations
Vilya-2 is the structure-prediction oracle that de novo peptide design pipelines require--establishing the all-atom approach as a general foundation for the design and evaluation of de novo peptide therapeutics.
Pascal Sturmfels, Naozumi Hiranuma, Milad Salem et al.· arXiv.org· 0 citations
Mapping the protein interactome is fundamental to understanding disease mechanisms and facilitating therapeutic development. Although protein language models (PLMs) such as ESM-2 have advanced protein-protein interaction (PPI) prediction, their high-dimensional representations remain difficult to connect to verifiable...
T. T. Nguyen, X. Mai, N. Nguyen· IEEE Access· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.